NCT07185152Completed
The Effect of Mechanical Vibration and Flick Tapping Methods in Reducing Pain in Infant Vaccination
The Effect of Mechanical Vibration and Flick Tapping Methods in Reducing Pain During Hepatitis B Vaccine Administration in Infants
Source: ClinicalTrials.gov · Last updated 22 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
A research protocol examining the effect of vibration on the crying duration variable in needle-related medical procedures in newborns also predicted that vibration therapy would be effective in reducing pain caused by vaccine injection and shortening the newborn's crying time. Flicking the injection site can be used to control pain in childhood. To date, only one experimental study testing the flick method has reported that the flick method applied before intramuscular injection had lower pain scores in babies during and after vaccination. Studies show that the positive effects of both methods are mentioned. However, no study has been found to examine the effects of both methods on injection pain that may occur when the second dose of Hepatitis B vaccine is administered in the neonatal period and compare their effects. The fact that the effects of mechanical vibration and flicking methods as pain relief strategies on reducing pain, physiological parameters and crying duration have not been examined in this population before shows the deficiency in the literature.This study aimed to examine the effect of flicking the injection site before the second dose of the Hepatitis B vaccine applied to the anterior surface of the vastus lateralis muscle in infancy and applying mechanical vibration to the injection site throughout the vaccination procedure on acute pain, crying duration and physiological parameters that may occur due to intramuscular injection.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 80 (actual)
- First submitted
- 3 Sept 2025
- Start date
- 29 Apr 2024
- Primary completion date
- 22 Apr 2025
- Lead sponsor
- Berrin GOGER
- Diseases
- Hepatitis B
- NCT number
- NCT07185152
What you commit to
- Study type: Interventional
- Participants enrolled: 80
- From 29 Apr 2024 to the primary completion date, 22 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Lab values
- Gestasyonel yaşı 38. haftanın altında 42. haftanın üzerinde olan bebekler,
Other
- Araştırmaya katılmayı kabul etmeyen anneler,
- Konjenital hastalık veya doğumsal anomalisi olan bebekler olarak belirlendi.
Who the study is looking for
- Mothers agreeing to participate in the study,
- The baby's gestational age being between 38 and 42 weeks,
- Babies being 30-42 days old after birth,
- The baby's birth weight being between 2500 g and 4000 g
- The infant has not been given pain medication prior to vaccination and has a normal body temperature.
Age in the registry: 30 days to 42 days · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kelkit No. 1 Family Health Center Coordinator of this site? Confirm its status | Gümüşhane | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.